AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $593,520 | -12.7% | 24,000 | 0.0% | 0.20% | -3.4% |
Q2 2023 | $679,680 | -96.8% | 24,000 | +4942.0% | 0.21% | -7.6% |
Q2 2022 | $21,500,000 | +2941.0% | 476 | -97.8% | 0.22% | +40.9% |
Q1 2022 | $707,000 | 0.0% | 21,500 | 0.0% | 0.16% | +0.6% |
Q4 2021 | $707,000 | -28.7% | 21,500 | 0.0% | 0.16% | -33.9% |
Q3 2021 | $992,000 | -16.3% | 21,500 | 0.0% | 0.24% | -23.6% |
Q2 2021 | $1,185,000 | +6.9% | 21,500 | 0.0% | 0.31% | +6.8% |
Q1 2021 | $1,108,000 | +18.9% | 21,500 | 0.0% | 0.29% | +14.9% |
Q4 2020 | $932,000 | +23.9% | 21,500 | 0.0% | 0.26% | +4.9% |
Q3 2020 | $752,000 | -34.0% | 21,500 | 0.0% | 0.24% | -35.9% |
Q2 2020 | $1,139,000 | +49.5% | 21,500 | 0.0% | 0.38% | +9.2% |
Q1 2020 | $762,000 | -56.3% | 21,500 | -41.1% | 0.35% | -44.7% |
Q4 2019 | $1,743,000 | +47.7% | 36,500 | 0.0% | 0.63% | +15.2% |
Q3 2019 | $1,180,000 | -35.2% | 36,500 | 0.0% | 0.54% | -19.3% |
Q2 2019 | $1,821,000 | -26.0% | 36,500 | 0.0% | 0.68% | -25.8% |
Q1 2019 | $2,462,000 | +86.4% | 36,500 | 0.0% | 0.91% | +11.0% |
Q4 2018 | $1,321,000 | -38.8% | 36,500 | 0.0% | 0.82% | -20.1% |
Q3 2018 | $2,159,000 | -29.8% | 36,500 | 0.0% | 1.03% | -13.1% |
Q2 2018 | $3,074,000 | +3.0% | 36,500 | 0.0% | 1.18% | +1.4% |
Q1 2018 | $2,985,000 | +161.2% | 36,500 | +82.5% | 1.16% | +188.8% |
Q4 2017 | $1,143,000 | -14.3% | 20,000 | 0.0% | 0.40% | -22.4% |
Q3 2017 | $1,334,000 | -29.9% | 20,000 | -45.9% | 0.52% | -28.3% |
Q2 2017 | $1,904,000 | +63.0% | 37,000 | +85.0% | 0.72% | +62.0% |
Q1 2017 | $1,168,000 | – | 20,000 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |